Bu Yin

• Patent application drafting and prosecution for a company developing nucleic acid sequencing devices and consumables
• Patentability and freedom-to-operate analysis for the investment arm of a Chinese biopharmaceutical company relating to potential investment in a company developing siRNA therapeutics
• Portfolio management, company side IP due diligence, patent term extension for a clinical-stage company developing gene therapies for oncology, dermatology, and pulmonology indications*
• IPO due diligence, cross-border R&D collaboration, and patent prosecution for a multinational biopharmaceutical company developing immuno-oncology and vaccine products*
• Patent application drafting and prosecution, pre-litigation counseling, and advice on interference proceedings for a company developing disease screening tests using cell-free DNA sequencing*
• Global patent portfolio management and collaboration for a developer of engineered insects for disease and agricultural pest control*
• Patent prosecution for global biopharma companies relating to kinase inhibitors, checkpoint inhibitors, cytokines, small peptide therapeutics, TCR-like antibodies, diagnostic and prognostic biomarkers, glyco-engineered therapeutics, personalized medicine, and various combination therapies*
• All aspects of patent counseling for a company developing soft robotic endoscopy products*
• All aspects of patent counseling for a company developing ophthalmic surgical devices, drug formulations, and companion diagnostics*
• Litigation support for a case involving a groundbreaking antibody platform technology*
• Litigation support for a case involving recombinant production and chromatographic purification of therapeutic proteins from a plant host*
• IP due diligence for various investors in matters involving self-replicating RNA/self-amplifying RNA technologies, CRIPSR/Cas, lateral flow tests (e.g., at-home tests for pregnancy, HIV, or COVID-19), solid phase DNA sequencing devices, microbiome-inspired feed supplements for livestock, microbial fertilizers, precision fermentation, edible coating for fruits and vegetables, alternative nature-equivalent proteins, biocatalysts, synthetic pheromones for insect control, engineered organisms such as insects and plants, dental devices, interventional pulmonology, and vascular medical devices*

*Denotes representations handled by Bu prior to joining DLA Piper.